[go: up one dir, main page]

ZA9510066B - Compounds for inhibition of gastric acid secretion - Google Patents

Compounds for inhibition of gastric acid secretion

Info

Publication number
ZA9510066B
ZA9510066B ZA9510066A ZA9510066A ZA9510066B ZA 9510066 B ZA9510066 B ZA 9510066B ZA 9510066 A ZA9510066 A ZA 9510066A ZA 9510066 A ZA9510066 A ZA 9510066A ZA 9510066 B ZA9510066 B ZA 9510066B
Authority
ZA
South Africa
Prior art keywords
inhibition
compounds
gastric acid
acid secretion
secretion
Prior art date
Application number
ZA9510066A
Other languages
English (en)
Inventor
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9510066B publication Critical patent/ZA9510066B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
ZA9510066A 1994-12-08 1995-11-27 Compounds for inhibition of gastric acid secretion ZA9510066B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/351,852 US5556863A (en) 1993-06-11 1994-12-08 Compound for gastric acid secretion inhibition

Publications (1)

Publication Number Publication Date
ZA9510066B true ZA9510066B (en) 1996-06-10

Family

ID=23382690

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510066A ZA9510066B (en) 1994-12-08 1995-11-27 Compounds for inhibition of gastric acid secretion

Country Status (20)

Country Link
US (1) US5556863A (es)
EP (1) EP0796249A1 (es)
JP (1) JPH10510259A (es)
CN (1) CN1169142A (es)
AR (1) AR001996A1 (es)
BR (1) BR9509888A (es)
CA (1) CA2205896A1 (es)
EE (1) EE9700131A (es)
FI (1) FI972410L (es)
HU (1) HUT77949A (es)
IL (1) IL116285A0 (es)
IS (1) IS4485A (es)
MX (1) MX9704136A (es)
NO (1) NO972529L (es)
NZ (1) NZ297566A (es)
PL (1) PL320754A1 (es)
SK (1) SK63797A3 (es)
TR (1) TR199501536A2 (es)
WO (1) WO1996017830A1 (es)
ZA (1) ZA9510066B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042702A (en) * 1973-08-16 1977-08-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them
LU69428A1 (es) * 1974-02-20 1975-12-09
US4120972A (en) * 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Imidazolylmethylthio-ethyl isothiourea compounds
NO760996L (es) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
AT364354B (de) * 1976-10-14 1981-10-12 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
YU118379A (en) * 1978-05-24 1983-02-28 Byk Gulden Lomberg Chemischefa Process for preparing phenylaminothiophene acetic acid
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
AU529934B2 (en) * 1979-08-03 1983-06-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tetraazatricyclic compounds
EP0024638A1 (en) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them
ES496382A0 (es) * 1979-10-31 1982-03-01 Byk Gulden Lomberg Chem Fab Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
US4381301A (en) * 1980-05-07 1983-04-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
EP0046961B1 (de) * 1980-08-29 1985-02-13 Byk Gulden Lomberg Chemische Fabrik GmbH Epoxi-cycloalkylalkancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie sie enthaltende Arzneimittel
DE3262922D1 (en) * 1981-02-02 1985-05-15 Byk Gulden Lomberg Chem Fab Tricyclic pyrrols, process for their preparation, their use and compositions containing them
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
DK585485A (da) * 1984-12-18 1986-08-08 Utsuka Pharm Co Ltd Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse
US5250527A (en) * 1985-10-24 1993-10-05 Smithkline & French Laboratories Limited Pyridyl containing benzimidazoles, compositions and use
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5049567A (en) * 1988-02-25 1991-09-17 Smithkline Beckman Intercredit B.V. Substituted 4-aminoquinazoline derivatives and method of use
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
GB8908229D0 (en) * 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
DK0480052T3 (da) * 1990-03-28 1998-05-11 Otsuka Pharma Co Ltd Quinolinderivat, antiulcus-lægemiddel indeholdende derivatet og fremstilling af derivatet
MA22401A1 (fr) * 1991-01-29 1992-10-01 Smithkline Beecham Intercredit Procede de preparation de sels de guinoleine
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru

Also Published As

Publication number Publication date
CA2205896A1 (en) 1996-06-13
IL116285A0 (en) 1996-03-31
AU697006B2 (en) 1998-09-24
AR001996A1 (es) 1998-01-07
FI972410A0 (fi) 1997-06-06
PL320754A1 (en) 1997-10-27
NO972529D0 (no) 1997-06-03
BR9509888A (pt) 1997-10-21
AU4274896A (en) 1996-06-26
EP0796249A1 (en) 1997-09-24
SK63797A3 (en) 1998-07-08
JPH10510259A (ja) 1998-10-06
HUT77949A (hu) 1998-12-28
MX9704136A (es) 1998-02-28
CN1169142A (zh) 1997-12-31
FI972410A7 (fi) 1997-06-06
NZ297566A (en) 1998-12-23
FI972410L (fi) 1997-06-06
US5556863A (en) 1996-09-17
IS4485A (is) 1997-05-22
WO1996017830A1 (en) 1996-06-13
EE9700131A (et) 1997-12-15
NO972529L (no) 1997-06-03
TR199501536A2 (tr) 1996-07-21

Similar Documents

Publication Publication Date Title
IL131122A0 (en) Compounds for inhibition of gastric acid secretion
ZA9810468B (en) Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
ZA951322B (en) Process for the preparation of polyalkyl-1-oxa-diazaspiro-decane compounds
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
IL116285A0 (en) Compounds for inhibition of gastric acid secretion
AU4019395A (en) Use of amino-isoxazolidone compounds for improvement of implicit memory
HU914068D0 (en) New gastrocitoprotective medical preparation for preventing gastric acid secretion
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
HK1002151A (en) Compounds for inhibition of gastric acid secretion
HUT73512A (en) Filteraparatus for dewatering of sludges
AU4676393A (en) Compounds for inhibition of proteolysis
HRP920125A2 (en) Process for the preparation of novel arylaminocarbonyl compounds
GB2312990B (en) Device for production of compound semiconductor
IL121588A0 (en) Process for the preparation of acid chloride compounds
SI1042324T1 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HUT65840A (en) Methode for dewatering of gully-holes
IL114089A0 (en) Methods for the preparation of alpha-chloroacetoacetanilide compounds
HU614U (en) Equipment for inhibition of starting of vehicles
IL135495A0 (en) Intermediate compounds for the preparation of substituted quinoline -2- carboxylic acid amides
AU530684B2 (en) Inhibition of gastric acid secretion
BG96587A (en) Method for the preparation of isoxasolpenicillin compounds
ZA977527B (en) Process for the preparation of acid chloride compounds
GB9418295D0 (en) Preparation of indoloquinone compounds
HU9701609D0 (en) Additive for inhibition of oxidation of amines
HU9403029D0 (en) Praess for preparation of n-methoxy-acetyl-anilines